8-K
filed November 18, 2022, 6:59 PM ET
ticker ARMP
CIK 0000921114
other material
confidence high
sentiment neutral
materiality 0.15
Armata shareholders elect seven directors, approve executive compensation, ratify EY auditor
Armata Pharmaceuticals, Inc.
- All seven director nominees elected with between 30.2M and 31.0M votes for each; broker non-votes 858,850.
- Non-binding advisory vote on 2021 executive compensation passed: 31,049,313 for, 28,667 against, 14,615 abstain.
- Ratification of Ernst & Young as independent auditor for FY2022 passed: 31,938,703 for, 6,798 against, 5,944 abstain.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Armata Pharmaceuticals, Inc. shareholders approved Advisory vote to approve Armata’s 2021 executive compensation at the 2022-11-16 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2022-11-16
Exact text from the filing
our shareholders next approved on a non-binding advisory basis, Armata’s 2021 executive compensation. The vote for such approval was 31,049,313 shares for, 28,667 shares against, 14,615 shares abstaining, and 858,850 shares of broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Armata Pharmaceuticals, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2022 at the 2022-11-16 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-11-16
Exact text from the filing
our shareholders ratified the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. The vote for such ratification was 31,938,703 shares for, 6,798 shares against, 5,944 shares abstaining, and 0 shares of broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Armata Pharmaceuticals, Inc. shareholders approved Election of seven directors to the board of directors at the 2022-11-16 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-11-16
Exact text from the filing
the shareholders of Armata Pharmaceuticals, Inc. (“Armata”) elected seven members to our board of directors, each for a one-year term expiring at the annual meeting of shareholders in 2023, as follows: Members Number of Shares Voted For Number of Shares Voted Against or Abstained Broker Non- Votes Brian Varnum, Ph. D. 30,859,084 233,511 858,850 Jules Haimovitz 30,207,477 885,118 858,850 Odysseas D. Kostas, M.D. 30,227,120 865,475 858,850 Robin C. Kramer 30,968,830 123,765 858,850 Joseph M. Patti, Ph. D. 30,966,995 125,600 858,850 Todd C. Peterson, Ph. D. 30,966,799 125,796 858,850 Sarah Schlesinger, M.D. 30,862,657 229,938 858,850
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.